2m 2m 2m 2m 2m 2m 2m
Viatris (VTRS)
NASDAQ
$15.58+$0.20 (+1.30%)
Price as of Jun 23, 2026 6:51 PM EDT- $17.9BMarket Cap
- 80.63%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Viatris (VTRS)
$15.58+$0.20 (+1.30%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 14.3B -2.98% | 14.7B -4.46% | 15.4B -5.14% | 16.3B -9.08% | |
Cost of Revenue | 9.3B +1.87% | 9.1B +1.42% | 9.0B -7.96% | 9.8B -20.67% | |
Gross Profit | 5.0B -10.85% | 5.6B -12.66% | 6.4B -0.90% | 6.5B +16.53% | |
Sales and Marketing Expense | 3.8B -14.27% | 4.4B -4.83% | 4.7B +11.27% | 4.2B -7.73% | |
Research and Development Expense | -965.9M +19.44% | -808.7M +0.43% | -805.2M +15.26% | -698.6M -6.99% | |
Depreciation and Amortization Expense | 2.8B -3.28% | 2.9B +5.57% | 2.7B -9.48% | 3.0B -32.82% | |
Total Operating Expenses | 7.7B +36.75% | 5.6B -1.04% | 5.7B +16.19% | 4.9B -12.97% | |
Operating Profit | -2.7B -26,467.33% | 10.1M -98.68% | 766.2M -52.55% | 1.6B +4,849.71% | |
Interest Income | N/A N/A | N/A N/A | 62.1M N/A | N/A N/A | |
Interest Expense | -471.3M -14.31% | -550.0M -4.03% | -573.1M -3.26% | -592.4M -6.88% | |
Interest Income and Expense and Net | -471.3M -14.31% | -550.0M +7.63% | -511.0M -13.74% | -592.4M -6.88% | |
Total Nonoperating Income and Expense | -530.6M +536.97% | -83.3M -950.00% | 9.8M -99.45% | 1.8B +30,774.14% | |
Income before Taxes | -3.7B +488.09% | -623.2M -407.15% | 202.9M -92.79% | 2.8B +523.42% | |
Income Taxes | -150.1M -1,464.55% | 11.0M -92.58% | 148.2M -79.83% | 734.6M +21.48% | |
Extraordinary Items | 184.6M -74.87% | 734.7M N/A | N/A N/A | N/A N/A | |
Net Income | -3.5B +454.23% | -634.2M -1,259.41% | 54.7M -97.37% | 2.1B +263.79% | |
Net Income from Continuing Operations Applicable to Common | -3.7B +488.09% | -623.2M -407.15% | 202.9M -92.79% | 2.8B +523.42% | |
Basic EPS and Net Income | -3.00 +466.04% | -0.53 -1,160.00% | 0.05 -97.08% | 1.71 +262.86% | |
Diluted EPS and Net Income | -3.00 +466.04% | -0.53 -1,160.00% | 0.05 -97.08% | 1.71 +262.86% | |
Basic Weighted Average Shares | 1.2B -0.97% | 1.2B +0.27% | 1.2B -0.27% | 1.2B +0.27% | |
Diluted Weighted Average Shares | 1.2B -0.86% | 1.2B +0.71% | 1.2B -0.71% | 1.2B +0.71% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.3B +79.97% | 734.8M -25.92% | 991.9M -21.27% | 1.3B +79.68% | |
Short-Term Investments | 40.7M +7.11% | 38.0M +2.70% | 37.0M +4.82% | 35.3M -7.59% | |
Cash and Cash Equivalents and Short-Term Investments | 1.4B +76.38% | 772.8M -24.89% | 1.0B -20.56% | 1.3B +75.17% | |
Total Current Assets | 9.8B +2.82% | 9.5B -26.63% | 13.0B +22.01% | 10.6B -2.45% | |
Accumulated Depreciation | 2.5B +14.41% | 2.2B +9.57% | 2.0B -2.36% | 2.1B -14.21% | |
Property and Plant and Equipment and Net | 2.6B -1.95% | 2.7B -3.39% | 2.8B -8.76% | 3.0B -5.15% | |
Total Long-Term Assets | 1.9B -20.58% | 2.4B +6.71% | 2.2B -8.10% | 2.4B +105.30% | |
Total Assets | 37.2B -10.38% | 41.5B -12.97% | 47.7B -4.67% | 50.0B -8.79% | |
Income Taxes Payable | 1.0B -21.88% | 1.3B -33.73% | 2.0B -27.63% | 2.7B -11.15% | |
Total Short-Term Debt | 1.9B +23,192.77% | 8.3M -99.57% | 1.9B +54.35% | 1.3B -62.64% | |
Total Current Liabilities | 7.1B +22.75% | 5.8B -25.69% | 7.8B +15.29% | 6.7B -31.75% | |
Total Long-Term Debt | 12.5B -11.10% | 14.0B -13.28% | 16.2B -10.14% | 18.0B -8.63% | |
Total Long-Term Liabilities | 2.0B +3.90% | 1.9B +27.84% | 1.5B -13.64% | 1.8B -9.16% | |
Total Liabilities | 22.5B -1.68% | 22.9B -15.99% | 27.2B -5.98% | 28.9B -15.72% | |
Retained Earnings | -388.3M -111.36% | 3.4B -26.31% | 4.6B -10.35% | 5.2B +40.31% | |
Total Stockholders Equity | 14.7B -21.06% | 18.6B -8.95% | 20.5B -2.87% | 21.1B +2.83% | |
Total Shares Outstanding | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | 2.3B +0.56% | 2.3B -17.74% | 2.8B -5.18% | 3.0B -2.13% | |
Capital Expenditures | 378.8M +16.20% | 326.0M -13.53% | 377.0M -7.14% | 406.0M -11.20% | |
Cash from Investing Activities | -427.7M -123.75% | 1.8B +335.66% | -764.1M -150.25% | 1.5B +1,390.75% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.3B -70.12% | -4.3B +88.12% | -2.3B -40.64% | -3.9B +28.75% | |
Financials Ratio | |||||
Gross Margin | 35.06% -8.11% | 38.15% -8.58% | 41.74% +4.47% | 39.95% +28.16% | |
Operating Margin | -18.62% -27,287.15% | 0.07% -98.62% | 4.97% -49.98% | 9.93% +5,323.62% | |
Return on Assets | -8.93% +528.12% | -1.42% -1,369.82% | 0.11% -97.17% | 3.96% +281.79% | |
Return on Equity | -21.08% +549.90% | -3.24% -1,331.47% | 0.26% -97.37% | 10.00% +271.20% | |
Revenue Growth | -2.98% -33.12% | -4.46% -13.28% | -5.14% -43.38% | -9.08% -118.25% | |
Current Ratio | 1.38 -16.24% | 1.65 -1.26% | 1.67 +5.83% | 1.58 +42.93% | |
Cash Ratio | 0.19 +46.66% | 0.13 -0.31% | 0.13 -31.75% | 0.19 +163.47% | |
Debt-to-Equity Ratio | 0.98 +29.98% | 0.75 -14.91% | 0.89 -3.15% | 0.91 -18.81% | |
Debt-to-Assets Ratio | 0.39 +14.48% | 0.34 -10.97% | 0.38 -1.32% | 0.39 -8.48% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow